GM Advisory Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.14M | Sell |
17,762
-392
| -2% | -$45.3K | 0.08% | 106 |
|
|
2025
Q4 | $1.91M | Buy |
18,154
+2,564
| +16% | +$241K | 0.07% | 111 |
|
|
2025
Q3 | $1.31M | Sell |
15,590
-4,412
| -22% | -$363K | 0.06% | 133 |
|
|
2025
Q2 | $1.58M | Buy |
20,002
+292
| +1% | +$23.2K | 0.08% | 110 |
|
|
2025
Q1 | $1.77M | Sell |
19,710
-39,271
| -67% | -$3.67M | 0.1% | 93 |
|
|
2024
Q4 | $5.87M | Buy |
58,981
+15,144
| +35% | +$1.56M | 0.32% | 49 |
|
|
2024
Q3 | $4.98M | Buy |
43,837
+1,463
| +3% | +$174K | 0.3% | 51 |
|
|
2024
Q2 | $5.25M | Sell |
42,374
-360
| -0.8% | -$46.4K | 0.34% | 50 |
|
|
2024
Q1 | $5.64M | Buy |
42,734
+10,771
| +34% | +$1.33M | 0.4% | 43 |
|
|
2023
Q4 | $3.48M | Buy |
31,963
+11,342
| +55% | +$1.18M | 0.26% | 46 |
|
|
2023
Q3 | $2.12M | Sell |
20,621
-219
| -1% | -$23.6K | 0.17% | 53 |
|
|
2023
Q2 | $2.4M | Buy |
20,840
+3,695
| +22% | +$420K | 0.2% | 50 |
|
|
2023
Q1 | $1.82M | Buy |
17,145
+7,410
| +76% | +$800K | 0.17% | 53 |
|
|
2022
Q4 | $1.08M | Hold |
9,735
| – | – | 0.12% | 66 |
|
|
2022
Q3 | $838K | Sell |
9,735
-85
| -0.9% | -$7.59K | 0.11% | 73 |
|
|
2022
Q2 | $895K | Sell |
9,820
-5
| -0.1% | -$443 | 0.14% | 72 |
|
|
2022
Q1 | $806K | Sell |
9,825
-4,370
| -31% | -$345K | 0.1% | 101 |
|
|
2021
Q4 | $1.09M | Buy |
14,195
+140
| +1% | +$11.2K | 0.1% | 91 |
|
|
2021
Q3 | $1.06M | Buy |
14,055
+280
| +2% | +$21.3K | 0.11% | 93 |
|
|
2021
Q2 | $1.07M | Sell |
13,775
-3,759
| -21% | -$280K | 0.11% | 91 |
|
|
2021
Q1 | $1.29M | Sell |
17,534
-7,514
| -30% | -$554K | 0.15% | 70 |
|
|
2020
Q4 | $1.96M | Sell |
25,048
-3,344
| -12% | -$256K | 0.26% | 49 |
|
|
2020
Q3 | $2.25M | Buy |
28,392
+678
| +2% | +$53.1K | 0.34% | 40 |
|
|
2020
Q2 | $2.04M | Buy |
27,714
+2,015
| +8% | +$152K | 0.38% | 41 |
|
|
2020
Q1 | $1.89M | Buy |
25,699
+23,303
| +973% | +$1.83M | 0.51% | 33 |
|
|
2019
Q4 | $208K | Buy |
+2,396
| New | +$197K | 0.06% | 90 |
|
|
2018
Q2 | – | Sell |
-5,402
| Closed | -$281K | – | 128 |
|
|
2018
Q1 | $281K | Hold |
5,402
| – | – | 0.08% | 95 |
|
|
2017
Q4 | $290K | Buy |
+5,402
| New | +$299K | 0.08% | 95 |
|
|
2017
Q3 | – | Sell |
-3,326
| Closed | -$205K | – | 118 |
|
|
2017
Q2 | $205K | Buy |
+3,326
| New | +$202K | 0.06% | 108 |
|
|
2017
Q1 | – | Sell |
-3,618
| Closed | -$206K | – | 114 |
|
|
2016
Q4 | $206K | Buy |
+3,618
| New | +$212K | 0.07% | 104 |
|
|
2015
Q1 | – | Sell |
-6,919
| Closed | -$375K | – | 63 |
|
|
2014
Q4 | $375K | Sell |
6,919
-271
| -4% | -$15.1K | 0.2% | 41 |
|
|
2014
Q3 | $407K | Buy |
7,190
+38
| +0.5% | +$2.13K | 0.31% | 35 |
|
|
2014
Q2 | $395K | Sell |
7,152
-545
| -7% | -$29.7K | 0.34% | 39 |
|
|
2014
Q1 | $419K | Sell |
7,697
-62
| -0.8% | -$3.21K | 0.33% | 37 |
|
|
2013
Q4 | $371K | Buy |
+7,759
| New | +$355K | 0.38% | 36 |
|
Other funds holding MRK
VCM
VPM
GM Advisory Group's MRK Position: Q1 2026 in Review
GM Advisory Group reduced its Merck (MRK) stake by 2.2% in Q1 2026, selling an estimated $45.3K and leaving 17,762 shares worth $2.14M. The position accounts for 0.08% of the portfolio, ranked #106.
GM Advisory Group first reported a position in MRK in Q4 2013 and has held it in 35 quarters since. The position peaked at $5.87M in Q4 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- GM Advisory Group held 17,762 shares of Merck worth $2.14M as of Q1 2026.
- GM Advisory Group sold 392 Merck shares in Q1 2026, an estimated $45.3K.
- Merck made up 0.08% of GM Advisory Group's portfolio in Q1 2026, its #106 holding.
- GM Advisory Group first reported a position in Merck in Q4 2013 and has held it in 35 quarters since.
- GM Advisory Group's Merck position peaked at $5.87M in Q4 2024.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.